Using the AI, a young scientist Mohan Vamsi Nallapareddy and his team developed an AI tool, which can predict ...

Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...

CVS to Pay $37.8 Million to Settle Overbilling Claims - CVS Pharmacy, Inc. agreed to pay $37.8 million to settle several lawsuits ...

Discover why Wave Life Sciences Ltd. is a high-risk, high-reward biotech with unique RNA therapies for AATD, obesity, and ...

A combination of two therapies, azacitidine and venetoclax, or aza-ven, outperformed intensive chemotherapy for acute myeloid leukemia in patients healthy enough to receive aggressive treatment, ...

Khaberni - The endocrinology and diabetes consultant, visiting consultant at Dasman Diabetes Institute, Dr. Thamer Mohammed Al-Essa, asserted that “the percentage of people affected by diabetes in ...

Researchers from ETH Zurich have succeeded in introducing large quantities of unnatural amino acids into bacteria, enabling ...

Type 1 diabetes is a disease in which the body mistakenly attacks itself as the immune system destroys the pancreas's insulin ...

Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...

Adding to the growing body of research that proves our microbiome is a powerful ally in fighting disease, scientists have ...

Gut-microbe–derived trimethylamine (TMA) blocks a key immune protein, reducing inflammation and improving blood-sugar control.

Researchers identified trimethylamine (TMA) as a gut microbe–derived metabolite that directly inhibits IRAK4 to reduce ...